These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The phosphotyrosine phosphatase eta mediates somatostatin inhibition of glioma proliferation via the dephosphorylation of ERK1/2. Massa A; Barbieri F; Aiello C; Iuliano R; Arena S; Pattarozzi A; Corsaro A; Villa V; Fusco A; Zona G; Spaziante R; Schettini G; Florio T Ann N Y Acad Sci; 2004 Dec; 1030():264-74. PubMed ID: 15659806 [TBL] [Abstract][Full Text] [Related]
3. [The activation of the phosphotyrosine phosphatase eta is responsible for the somatostatin inhibition of PCCl3 thyroid cell proliferation]. Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Villa V; Pattarozzi A; Diana F; Fusco A; Schettini G Minerva Endocrinol; 2001 Dec; 26(4):277-83. PubMed ID: 11782716 [TBL] [Abstract][Full Text] [Related]
4. Biology of somatostatin in breast cancer. Watt HL; Kharmate G; Kumar U Mol Cell Endocrinol; 2008 May; 286(1-2):251-61. PubMed ID: 18308465 [TBL] [Abstract][Full Text] [Related]
6. An intracellular multi-effector complex mediates somatostatin receptor 1 activation of phospho-tyrosine phosphatase eta. Arena S; Pattarozzi A; Massa A; Esteve JP; Iuliano R; Fusco A; Susini C; Florio T Mol Endocrinol; 2007 Jan; 21(1):229-46. PubMed ID: 17021051 [TBL] [Abstract][Full Text] [Related]
7. The activation of the phosphotyrosine phosphatase eta (r-PTP eta) is responsible for the somatostatin inhibition of PC Cl3 thyroid cell proliferation. Florio T; Arena S; Thellung S; Iuliano R; Corsaro A; Massa A; Pattarozzi A; Bajetto A; Trapasso F; Fusco A; Schettini G Mol Endocrinol; 2001 Oct; 15(10):1838-52. PubMed ID: 11579215 [TBL] [Abstract][Full Text] [Related]
8. Protein tyrosine phosphatases in osteoclast differentiation, adhesion, and bone resorption. Granot-Attas S; Elson A Eur J Cell Biol; 2008 Sep; 87(8-9):479-90. PubMed ID: 18342392 [TBL] [Abstract][Full Text] [Related]
9. SHP protein tyrosine phosphatase expression in rat uterine tissue. Phillippe M; Bradley DF; Engle D; Sweet L J Soc Gynecol Investig; 2006 Jul; 13(5):338-42. PubMed ID: 16814162 [TBL] [Abstract][Full Text] [Related]
10. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail. Poole AW; Jones ML Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691 [TBL] [Abstract][Full Text] [Related]
12. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2. Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098 [TBL] [Abstract][Full Text] [Related]
13. Novel signals mediating the functions of somatostatin: the emerging role of NO/cGMP. Thermos K Mol Cell Endocrinol; 2008 May; 286(1-2):49-57. PubMed ID: 18384933 [TBL] [Abstract][Full Text] [Related]
14. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z. Fukada M; Kawachi H; Fujikawa A; Noda M Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986 [TBL] [Abstract][Full Text] [Related]
15. Analyzing protein tyrosine phosphatases by phosphotyrosine analog integration. Shen K Methods; 2007 Jul; 42(3):234-42. PubMed ID: 17532510 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory and stimulatory effects of somatostatin on two human pancreatic cancer cell lines: a primary role for tyrosine phosphatase SHP-1. Douziech N; Calvo E; Coulombe Z; Muradia G; Bastien J; Aubin RA; Lajas A; Morisset J Endocrinology; 1999 Feb; 140(2):765-77. PubMed ID: 9927304 [TBL] [Abstract][Full Text] [Related]
17. Somatostatin receptor 1 (SSTR1)-mediated inhibition of cell proliferation correlates with the activation of the MAP kinase cascade: role of the phosphotyrosine phosphatase SHP-2. Florio T; Thellung S; Arena S; Corsaro A; Bajetto A; Schettini G; Stork PJ J Physiol Paris; 2000; 94(3-4):239-50. PubMed ID: 11088001 [TBL] [Abstract][Full Text] [Related]
18. Somatostatin receptors 1 and 5 heterodimerize with epidermal growth factor receptor: agonist-dependent modulation of the downstream MAPK signalling pathway in breast cancer cells. Watt HL; Kharmate GD; Kumar U Cell Signal; 2009 Mar; 21(3):428-39. PubMed ID: 19070659 [TBL] [Abstract][Full Text] [Related]
19. Potential indications for somatostatin analogues: immune system and limphoproliferative disorders. Ferone D; Resmini E; Boschetti M; Arvigo M; Albanese V; Ceresola E; Pivonello R; Albertelli M; Bianchi F; Giusti M; Minuto F J Endocrinol Invest; 2005; 28(11 Suppl International):111-7. PubMed ID: 16625859 [TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatases and breast cancer. Freiss G; Vignon F Crit Rev Oncol Hematol; 2004 Oct; 52(1):9-17. PubMed ID: 15363463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]